Aseem Undvall Anand

knuten till universitetet
Fler filtreringsmöjligheter
  1. 2018
  2. Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer a secondary analysis of a randomized clinical trial

    Armstrong, A. J., Aseem Anand, Edenbrandt, L., Bondesson, E., Anders Bjartell, Widmark, A., Sternberg, C. N., Pili, R., Tuvesson, H., Nordle, Ö., Carducci, M. A. & Morris, M. J., 2018 jul 1, I : JAMA oncology. 4, 7, s. 944-951 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2017
  4. Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer

    Josefsson, A., Linder, A., Flondell Site, D., Canesin, G., Stiehm, A., Aseem Anand, Anders Bjartell, Damber, J-E. & Welén, K., 2017 jun 1, I : Prostate. 77, 8, s. 849-858 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer

    Alva, A., Nordquist, L., Daignault, S., George, S., Ramos, J., Albany, C., Isharwal, S., McDonald, M., Campbell, G., Danchaivijitr, P., Yentz, S., Aseem Anand & Yu, E. Y., 2017 apr 1, I : Prostate. 77, 5, s. 479-488 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis

    Emelie Englund, Canesin, G., Konstantinos S. Papadakos, Neelanjan Vishnu, Persson, E., Reitsma, B., Aseem Anand, Jacobsson, L., Helczynski, L., Hindrik Mulder, Anders Bjartell & Anna M. Blom, 2017, I : Oncotarget. 8, 58, s. 98298-98311 14 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2016
  8. A preanalytic validation study of automated bone scan index: Effect on accuracy and reproducibility due to the procedural variabilities in bone scan image acquisition

    Aseem Anand, Morris, M. J., Kaboteh, R., Reza Felix, M., Elin Trägårdh, Matsunaga, N., Edenbrandt, L., Anders Bjartell, Larson, S. M. & David Minarik, 2016 dec 1, I : Journal of Nuclear Medicine. 57, 12, s. 1865-1871 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.

    Aseem Anand, Morris, M. J., Larson, S. M., David Minarik, Josefsson, A., Helgstrand, J. T., Oturai, P. S., Edenbrandt, L., Røder, M. A. & Anders Bjartell, 2016 mar 9, I : EJNMMI Research. 6, 1

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.

    Aseem Anand, Morris, M. J., Kaboteh, R., Båth, L., Sadik, M., Gjertsson, P., Lomsky, M., Edenbrandt, L., David Minarik & Anders Bjartell, 2016, I : Journal of Nuclear Medicine. 57, 1, s. 41-45

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice

    Reza Felix, M., Mattias Ohlsson, Kaboteh, R., Aseem Anand, Franck Lissbrant, I., Damber, J-E., Widmark, A., Thellenberg-Karlsson, C., Budäus, L., Steuber, T., Eichenauer, T., Per Wollmer, Edenbrandt, L., Elin Trägårdh & Anders Bjartell, 2016, I : European Urology Focus. 2, 5, s. 540-546 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections

    Agnieszka Krzyzanowska, Lippolis, G., Helczynski, L., Aseem Anand, Peltola, M., Pettersson, K., Lilja, H. & Anders Bjartell, 2016, I : Journal of Histochemistry and Cytochemistry. 64, 5, s. 311-322 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2015
  14. Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.

    Rathkopf, D. E., Larson, S. M., Aseem Anand, Morris, M. J., Slovin, S. F., Shaffer, D. R., Heller, G., Carver, B., Rosen, N. & Scher, H. I., 2015, I : Cancer. 121, 21, s. 3853-3861

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

    Aseem Anand & Anders Bjartell, 2015, I : European Urology. 67, 2, s. 349-350

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  16. 2007
  17. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Danila, DC., Heller, G., Gignac, GA., Gonzalez-Espinoza, R., Aseem Anand, Tanaka, E., Lilja, H., Schwartz, L., Larson, S., Fleisher, M. & Scher, HI., 2007, I : Clinical Cancer Research. 13, 23, s. 7053-7058

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift